spacer
home > ebr > winter 2022 > understanding the bottlenecks holding back biologics
PUBLICATIONS
European Biopharmaceutical Review

Understanding the Bottlenecks Holding Back Biologics

EBR: How has biologics production developed in recent years?

Alex Page: Prior to the pandemic, the answer to this question was fairly straightforward. Most of the focus was on developing continuous processing to improve downstream throughput, as well as the move towards ‘scaling out’ instead of ‘scaling up’ to help reduce risk and increase flexibility of production space.

While those concepts are still a critical element of most continuous improvement strategies in the industry, messenger RNA (mRNA) therapies have become a dominant subject whenever the future of biologics production is discussed. The previously unfathomable speed of highly efficacious mRNA COVID-19 vaccines, from discovery to approval, has shown the industry what is possible with this relatively new technology. The fallout of this will certainly have a significant effect on virtually every aspect of drug development, clinical trials, and commercialisation moving forwards. One of the most inspiring developments

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Alex Page is a National Sales Manager for the Life Science Division of Watson-Marlow Fluid Technology Group (WMFTG). Based in the US, he has over 19 years’ experience in the life science industry specialising in lab/ research, manufacturing, and medical devices. Alex joined WMFTG in 2016 to help drive the direct to market strategy in the US. Prior to this he worked for the life science division of Saint-Gobain Performance Plastics and Cole Parmer, focusing on single-use biological manufacturing. Alex began his career in technical sales representing Precision/Napco for Jouan Inc (now a ThermoFisher company), having gained a Bachelors of Science in Business Administration from Catawba College, US.
spacer
Alex Page
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Emmes Rapidly Expands in India – Driven By Deep Vaccines and Infectious Diseases Expertise and Enhanced Study Startup Capabilities

Global CRO’s India office reports surging growth from Western, regional and local trial customers
More info >>

White Papers
 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement